GlassScriptPhysician profile
Katrina V Gooden
NPI 1851663595
$2,413.13
in general payments reported to CMS, 2019-2025
36 companies · $764 in 2025
The $764 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.00 · 2022: $124 · 2023: $829 · 2024: $683 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,251 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,250.72 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $584.12 | 2023-2025 | Azstarys |
| Abbvie INC. | $245.42 | 2021-2024 | |
| Supernus Pharmaceuticals, INC. | $174.74 | 2023-2025 | Qelbree, Qelbree |
| Pfizer INC. | $164.44 | 2023-2025 | |
| Abbott Laboratories | $110.85 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $109.45 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Novo Nordisk INC | $91.90 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Ironshore Pharmaceuticals INC. | $61.17 | 2023-2024 | Jornay Pm |
| Verrica Pharmaceuticals INC. | $57.44 | 2024 | Ycanth |
| Xeris Pharmaceuticals, INC. | $53.06 | 2023-2025 | Gvoke Hypopen, Keveyis |
| Merck Sharp & Dohme LLC | $51.98 | 2024-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Exact Sciences Corporation | $51.59 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sage Therapeutics, LLC | $48.61 | 2024 | |
| Lilly USA, LLC | $47.76 | 2022-2023 | Mounjaro, Reyvow, Emgality |
| Neurelis, INC. | $47.21 | 2024-2025 | Valtoco |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Gooden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.